LSV ASSET MANAGEMENT – United Therapeutics Corporation Transaction History
LSV ASSET MANAGEMENT portfolio value:
$118.40M
portfolio value
LSV ASSET MANAGEMENT quarter portfolio value change:
-11.14%
quarter
United Therapeutics Corporation 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -4.38% | -25.9K shares | -20.95M | $209.38 | 565.52K |
Q2 2022 | share | Decrease | -0.50% | -2.98K shares | 32.72M | $235.64 | 591.42K |
Q1 2022 | share | Increase | +10.68% | 57.35K shares | -9.40M | $179.41 | 594.40K |
Q4 2021 | share | Increase | +2.43% | 12.76K shares | 19.27M | $215.18 | 537.05K |
Q3 2021 | share | Decrease | -5.30% | -29.34K shares | -2.55M | $184.58 | 524.28K |
Q2 2021 | share | Decrease | -3.45% | -19.77K shares | 3.41M | $179.41 | 553.62K |
Q1 2021 | share | Decrease | -4.25% | -25.42K shares | 5.01M | $167.27 | 573.39K |
Q4 2020 | share | Increase | +7.32% | 40.86K shares | 34.54M | $151.79 | 598.81K |
Q3 2020 | share | Increase | +7.71% | 39.92K shares | -6.32M | $101 | 557.95K |
Q2 2020 | share | Increase | +51.14% | 175.28K shares | 30.18M | $121 | 518.03K |
Q1 2020 | share | Increase | +74.52% | 146.35K shares | 15.20M | $94.83 | 342.74K |
Q4 2019 | share | Increase | +52.41% | 67.53K shares | 7.02M | $88.08 | 196.39K |
Q3 2019 | share | Decrease | -39.72% | -84.89K shares | -6.40M | $79.75 | 128.85K |
Q2 2019 | share | Decrease | -59.76% | -317.46K shares | -45.66M | $78.06 | 213.75K |
Q1 2019 | share | Decrease | -13.84% | -85.33K shares | -4.79M | $117.37 | 531.21K |
Q4 2018 | share | Increase | +20.87% | 106.46K shares | 1.91M | $108.9 | 616.54K |
Q3 2018 | share | Increase | +6.16% | 29.6K shares | 10.86M | $127.88 | 510.08K |
Q2 2018 | share | Increase | +14.31% | 60.14K shares | 7.13M | $113.15 | 480.48K |
Q1 2018 | share | Increase | +53.33% | 146.19K shares | 6.67M | $112.36 | 420.34K |
Q4 2017 | share | Increase | +59.78% | 102.56K shares | 20.45M | $147.95 | 274.14K |
Q3 2017 | share | Decrease | -63.63% | -300.23K shares | -41.10M | $117.19 | 171.58K |
Q2 2017 | share | Decrease | -62.66% | -791.85K shares | -109.86M | $129.73 | 471.82K |
Q1 2017 | share | Decrease | -1.44% | -18.4K shares | -12.81M | $135.38 | 1.26M |
Q4 2016 | share | Increase | +1.22% | 15.41K shares | 34.32M | $143.43 | 1.28M |
Q3 2016 | share | Increase | +2.93% | 36.01K shares | 19.21M | $118.08 | 1.26M |
Q2 2016 | share | Increase | +4.30% | 50.7K shares | -1.13M | $105.92 | 1.23M |
Q1 2016 | share | Increase | +67.50% | 475.49K shares | 21.15M | $111.43 | 1.17M |